Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sona Nanotech Inc C.SONA

Alternate Symbol(s):  SNANF

Sona Nanotech Inc. is a nanotechnology life sciences company, which is engaged in developing targeted hyperthermia therapy. The Company has developed multiple methods for the manufacturing of various types of gold nanoparticles (GNR). It is engaged in research and development of its technology for use in multiplex diagnostic testing platforms and advanced biomedical applications. Its gold nanotechnologies are adapted for use in applications, as a safe and delivery system for multiple medical treatments, for the approval of various regulatory boards, including Health Canada and the Food and Drug administration (FDA). Its gold nanorod particles are manufactured without the use of cetyltrimethylammonium bromide (CTAB), eliminating the toxicity risks associated with the use of other gold nanorod technologies in medical applications. The Company is focused on the development of a pre-clinical nanomedical therapy for the treatment of cancer using its biocompatible GNR.


CSE:SONA - Post by User

Comment by TheeRookon Dec 23, 2020 5:14pm
451 Views
Post# 32174586

RE:Face It

RE:Face It Unless the test is improved to    sensitivity of 98%, a specificity of 100%

SONA will be wasting their time applying to the FDA again.  Those are the accuracy of the latest tests the FDA is approving for shallow Swabs.   

No one will want to do deep swabs ever again if shallow swabs are available.

dart321 wrote: this company has until Feb 16th to get their act together and their share price back up or face a growing number of law suits. Doesn't matter if the suits have any standing or not the fact is they are there. So Feb 16th is their deadline it's their drop dead date. It was a total mistake to go after HC approval before the FDA, HC is nothing but a tag along for the FDA and the FDA was political because of the corruption of the Trump admin. Biden will let science be science. In my opinion if they submit more data to the FDA once Biden takes over they could have a chance of a quick approval providing the new data proves the test out with a larger study.


<< Previous
Bullboard Posts
Next >>